| Dec'17 | ||||||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Total comprehensive loss | ||||||
-8,141 | ||||||
Adjustments to profit or loss items: | ||||||
Net financing expenses | ||||||
154 | ||||||
Loss (gain) from revaluation of financial assets presented at fair value through profit or loss | ||||||
40 | ||||||
Depreciation | ||||||
107 | ||||||
Share-based payment | ||||||
1,553 | ||||||
Changes in fair value of warrants to ADS | ||||||
866 | ||||||
Adjustments to profit or loss items | ||||||
2,720 | ||||||
Changes in asset and liability items: | ||||||
Decrease (increase) in other receivables | ||||||
136 | ||||||
Decrease in trade and other payables | ||||||
117 | ||||||
Operating activities for changes in asset and liability | ||||||
253 | ||||||
Cash paid and received during the period for: | ||||||
Interest received | ||||||
42 | ||||||
Cash paid and received during the year | ||||||
0 | ||||||
Net cash used in operating activities | ||||||
-5,126 | ||||||
Cash flows from investing activities: | ||||||
Proceeds received from the sale of fixed assets | ||||||
0 | ||||||
Short-term deposits, net | ||||||
5,633 | ||||||
Restricted cash, net | ||||||
-47 | ||||||
Marketable securities measured at fair value through profit and loss, net | ||||||
-2,599 | ||||||
Purchase of property, plant and equipment | ||||||
77 | ||||||
Net cash provided by investing activities | ||||||
2,910 | ||||||
Cash flows from financing activities: | ||||||
Exercise of share options | ||||||
414 | ||||||
Issuance of share capital and warrants, net of issue costs | ||||||
4,148 | ||||||
Net cash provided by financing activities | ||||||
4,562 | ||||||
Exchange differences on balances of cash and cash equivalents | ||||||
-196 | ||||||
Increase (decrease) in cash and cash equivalents | ||||||
2,150 | ||||||
(a) Non-cash activities: | ||||||
Purchase of property, plant and equipment | ||||||
22 | ||||||
Issuance costs | ||||||
37 | ||||||